Cost-Effectiveness of Patent Foramen Ovale Closure versus Medical Therapy for Secondary Stroke Prevention

BACKGROUND AND PURPOSE: Percutaneous transcatheter closure of patent foramen ovale (PFO closure) plus antiplatelet therapy has been shown to reduce the risk of recurrent stroke compared to medical therapy alone in carefully selected patients following cryptogenic stroke presumed to be from paradoxic...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stroke
Autors principals: Leppert, Michelle H., Poisson, Sharon N., Carroll, John D., Thaler, David E., Chong, Kim H., Orjuela, Karen D., Ho, P. Michael, Burke, James F, Campbell, Jonathan D.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5970986/
https://ncbi.nlm.nih.gov/pubmed/29720435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.117.020322
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars